{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:05:41Z","timestamp":1778807141195,"version":"3.51.4"},"publisher-location":"Totowa, NJ","reference-count":82,"publisher":"Humana Press","isbn-type":[{"value":"9781627034043","type":"print"},{"value":"9781627034050","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-405-0_1","type":"book-chapter","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T14:35:38Z","timestamp":1365777338000},"page":"1-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vascular Proteomics"],"prefix":"10.1007","author":[{"given":"Maria G.","family":"Barderas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Vivanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Alvarez-Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"key":"1_CR00011","first-page":"III27","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27\u2013III32","journal-title":"Circulation"},{"key":"1_CR00012","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1586\/14789450.5.5.679","volume":"5","author":"G Alvarez-Llamas","year":"2008","unstructured":"Alvarez-Llamas G, de la Cuesta F, Barderas MG, Darde V, Padial LR, Vivanco F (2008) Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics 5:679\u2013691","journal-title":"Expert Rev Proteomics"},{"key":"1_CR00013","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395","journal-title":"Clin Pharmacol Ther"},{"key":"1_CR00014","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1208\/aapsj080122","volume":"8","author":"MJ Finley Austin","year":"2006","unstructured":"Finley Austin MJ, Babiss L (2006) Commentary: where and how could biomarkers be used in 2016. AAPS J 8:E185\u2013E189","journal-title":"AAPS J"},{"key":"1_CR00015","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/prca.201000073","volume":"4","author":"C Sturgeon","year":"2010","unstructured":"Sturgeon C, Hill R, Hortin GL, Thompson D (2010) Taking a new biomarker into routine use\u2014a perspective from the routine clinical biochemistry laboratory. Proteomics Clin Appl 4:892\u2013903","journal-title":"Proteomics Clin Appl"},{"key":"1_CR00016","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837\u20131847","journal-title":"Circulation"},{"key":"1_CR00017","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1373\/clinchem.2011.165795","volume":"58","author":"FS Apple","year":"2012","unstructured":"Apple FS, Collinson PO (2012) IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 58:54\u201361","journal-title":"Clin Chem"},{"key":"1_CR00018","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","volume":"120","author":"E Di Angelantonio","year":"2009","unstructured":"Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D et al (2009) B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120:2177\u20132187","journal-title":"Circulation"},{"key":"1_CR00019","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/4551054a","volume":"455","author":"JK Nicholson","year":"2008","unstructured":"Nicholson JK, Lindon LC (2008) Systems \u00adbiology: metabolomics. Nature 455:1054\u20131056","journal-title":"Nature"},{"key":"1_CR000110","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1875692110806030150","volume":"6","author":"RA Wike","year":"2008","unstructured":"Wike RA, Mereedu RK, Moore JH (2008) The pathway less traveled: moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scala pharmacogenetic association studies. Curr Pharmacogenomics Person Med 6:150\u2013159","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"1_CR000111","first-page":"43","volume":"13","author":"V Ozdemir","year":"2008","unstructured":"Ozdemir V, Suarez-Kurtz G, Stenne E, Somoggyi A, Kayaalp O, Kolker E (2008) Risk assessment and communication tools for genotype associations with multifactorial phenotypes: The concept of \u201cedge effect\u201d and cultivating an ethical bridge between omics innovations and society. J Integr Biol 13:43\u201362","journal-title":"J Integr Biol"},{"key":"1_CR000112","first-page":"3","volume":"728","author":"LA Beer","year":"2011","unstructured":"Beer LA, Tang H, Barnhart KT, Speicher DW (2011) Plasma biomarker discovery using 3D protein profiling coupled with label-free quantitation methods. Mol Biol 728:3\u201327","journal-title":"Mol Biol"},{"key":"1_CR000113","doi-asserted-by":"publisher","first-page":"M110.003699","DOI":"10.1074\/mcp.M110.003699","volume":"10","author":"SS Thakur","year":"2011","unstructured":"Thakur SS, Geiger T, Chatterjee B, Bandilla P, Fr\u00f6hlich F, Cox J, Mann M (2011) Deep and highly sensitive proteome coverage by LC-MS\/MS without prefractionation. Mol Cell Proteomics 10:M110.003699","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000114","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mas.20205","volume":"28","author":"H Mischak","year":"2009","unstructured":"Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra J, Dominiczak AF (2009) Capillary electrophoresis\u2014mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev 28:703\u2013724","journal-title":"Mass Spectrom Rev"},{"key":"1_CR000115","doi-asserted-by":"crossref","unstructured":"Barderas MG, Laborde CM, Posada M, de la Cuesta F, Zubiri I, Vivanco F, Alvarez-Llamas G (2011) Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases. J Biomed Biotechnol doi: 10.1155\/2011\/790132.","DOI":"10.1155\/2011\/790132"},{"key":"1_CR000116","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","volume":"58","author":"EP Rhee","year":"2012","unstructured":"Rhee EP, Gerszten RE (2012) Metabolomics and cardiovascular biomarker discovery. Clin Chem 58:139\u2013147","journal-title":"Clin Chem"},{"key":"1_CR000117","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/mas.20124","volume":"26","author":"LA McDonnell","year":"2007","unstructured":"McDonnell LA, Heeren RMA (2007) Imaging mass spectrometry. Mass Spectrom Rev 26:606\u2013643","journal-title":"Mass Spectrom Rev"},{"key":"1_CR000118","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/jmri.22266","volume":"32","author":"J Wang","year":"2010","unstructured":"Wang J, Balu N, Canton G, Yuan C (2010) Imaging biomarkers of cardiovascular disease. J Magn Reson Imaging 32:502\u2013515","journal-title":"J Magn Reson Imaging"},{"key":"1_CR000119","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/msb.2008.61","volume":"4","author":"V Lange","year":"2008","unstructured":"Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222","journal-title":"Mol Syst Biol"},{"key":"1_CR000120","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.M500006-MCP200","volume":"4","author":"TD Veenstra","year":"2005","unstructured":"Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG (2005) Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4:409\u2013418","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000121","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/jphysiol.2004.080473","volume":"563","author":"NL Anderson","year":"2005","unstructured":"Anderson NL (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 563:23\u201360","journal-title":"J Physiol"},{"key":"1_CR000122","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pmic.200390036","volume":"3","author":"YY Wang","year":"2003","unstructured":"Wang YY, Cheng P, Chan DW (2003) A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis. Proteomics 3:243\u2013248","journal-title":"Proteomics"},{"key":"1_CR000123","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/pmic.200400900","volume":"5","author":"K Bjorhall","year":"2005","unstructured":"Bjorhall K, Miliotis T, Davidsson P (2005) Interest of major serum protein removal for surface-enhanced laser desorption\/ionization\u2014time of flight (SELDI-TOF) proteomic blood profiling. Proteomics 5:307\u2013317","journal-title":"Proteomics"},{"key":"1_CR000124","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1373\/clinchem.2007.091736","volume":"53","author":"N Seam","year":"2007","unstructured":"Seam N, Gonzales DA, Kern SJ, Hortin GL, Hoehn GT, Suffredini AF (2007) Quality control of serum albumin depletion for proteomic analysis. Clin Chem 53:1915\u20131920","journal-title":"Clin Chem"},{"key":"1_CR000125","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1523-1755.2002.kid565.x","volume":"62","author":"V Thongboonkerd","year":"2002","unstructured":"Thongboonkerd V, McLeish KR, Arthur JM, Kelin JB (2002) Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 62:1461\u20131469","journal-title":"Kidney Int"},{"key":"1_CR000126","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/pmic.200401012","volume":"5","author":"V Thongboonkerd","year":"2007","unstructured":"Thongboonkerd V, Malasit P (2007) Renal and urinary proteomics: current applications and challenges. Proteomics 5:1033\u20131042","journal-title":"Proteomics"},{"key":"1_CR000127","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1074\/mcp.M700596-MCP200","volume":"7","author":"V Espina","year":"2008","unstructured":"Espina V et al (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7:1998\u20132018","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000128","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.274.5289.998","volume":"274","author":"MR Emmert-Buck","year":"1996","unstructured":"Emmert-Buck MR et al (1996) Laser capture microdissection. Science 274:998\u20131001","journal-title":"Science"},{"key":"1_CR000129","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1074\/mcp.M600265-MCP200","volume":"6","author":"G Alvarez-Llamas","year":"2007","unstructured":"Alvarez-Llamas G et al (2007) Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 6:589\u2013600","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000130","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.2337\/db10-0483","volume":"59","author":"SL Hocking","year":"2010","unstructured":"Hocking SL et al (2010) Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue-derived microvascular endothelial cells. Diabetes 59:3008\u20133016","journal-title":"Diabetes"},{"key":"1_CR000131","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387\u20131397","journal-title":"N Engl J Med"},{"key":"1_CR000132","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1161\/01.CIR.0000148981.71644.C7","volume":"110","author":"C Sidney","year":"2004","unstructured":"Sidney C, Smith J, Anderson JL, Cannon RO, Fadl YY, Koenig W, Libby P, Lipshultz SE, Mensah GA, Ridker PM, Rosenson R (2004) CDC\/AHA Workshop on markers of inflammation and cardiovascular disease application to clinical and public health practice: report from the Clinical Practice Discussion Group. Circulation 110:e550\u2013e555","journal-title":"Circulation"},{"key":"1_CR000133","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1002\/pmic.200400947","volume":"4","author":"M Mayr","year":"2004","unstructured":"Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q (2004) Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4:3751\u20133761","journal-title":"Proteomics"},{"issue":"4","key":"1_CR000134","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1586\/14737159.4.6.805","volume":"2004","author":"AJ Marian","year":"2004","unstructured":"Marian AJ, Nambi V (2004) Biomarkers of cardiac disease. Expert Rev Mol Diagn 2004(4):805\u2013820","journal-title":"Expert Rev Mol Diagn"},{"key":"1_CR000135","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1002\/pmic.200401308","volume":"5","author":"BT Berhane","year":"2005","unstructured":"Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmondson RD, Jones RC, Qiao X, Whitelegge JP, Ping P, Vondriska TM (2005) Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 5:3520\u20133530","journal-title":"Proteomics"},{"issue":"2","key":"1_CR000136","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2008.12.028","volume":"205","author":"D Brea","year":"2009","unstructured":"Brea D, Sobrino T, Blanco M, Fraga M, Agulla J, Rodriguez-Ya\u00f1ez M, Rodriguez-Gonzalez R, Perez de la Ossa N, Leira R, Forteza J, Davalos A, Castillo J (2009) Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnoses confirmation. Atherosclerosis 205(2):561\u2013567","journal-title":"Atherosclerosis"},{"issue":"6","key":"1_CR000137","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1371\/journal.pone.0000544","volume":"2","author":"SK Ganesh","year":"2007","unstructured":"Ganesh SK, Sharma Y, Dayhoff J, Fales HM, Van Eyk J, Kickler TS, Billings EM, Nabel EG (2007) Detection of venous thromboembolism by proteomic serum biomarkers. PLoS One 2(6):e544","journal-title":"PLoS One"},{"key":"1_CR000138","doi-asserted-by":"publisher","first-page":"e3224","DOI":"10.1371\/journal.pone.0003224","volume":"3","author":"RX Liu","year":"2008","unstructured":"Liu RX, Chen HB, Tu K, Zhao SH, Li SJ, Dai J, Li QR, Nie S, Li YX, Jia WP, Wu JR (2008) Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS One 3:e3224","journal-title":"PLoS One"},{"key":"1_CR000139","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1074\/mcp.M700394-MCP200","volume":"7","author":"LU Zimmerli","year":"2008","unstructured":"Zimmerli LU, Schiffer E, Z\u00fcrbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter KH, Mischak H, Kolch W, Delles C, Dominiczak AF (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 7:290\u2013298","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000140","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/prca.200800024","volume":"2","author":"J Coon","year":"2008","unstructured":"Coon J, Zurbig P, Dakna M, Dominiczak A, Decramer S et al (2008) CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2:964\u2013973","journal-title":"Proteomics Clin Appl"},{"key":"1_CR000141","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/pr800615t","volume":"8","author":"C Von zur Muhlen","year":"2009","unstructured":"Von zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 8:335\u2013345","journal-title":"J Proteome Res"},{"key":"1_CR000142","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0008-6363(03)00537-6","volume":"60","author":"W Martinet","year":"2003","unstructured":"Martinet W, Schrijvers DM, De Meyer GR, Herman AG, Kockx MM (2003) Western array analysis of human atherosclerotic plaques. Down regulation of apoptosis-linked gene 2. Cardiovasc Res 60:259\u2013267","journal-title":"Cardiovasc Res"},{"key":"1_CR000143","first-page":"165","volume":"357","author":"W Martinet","year":"2006","unstructured":"Martinet W (2006) Western array analysis of human atherosclerotic plaques. Methods Mol Biol 357:165\u2013178","journal-title":"Methods Mol Biol"},{"key":"1_CR000144","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.1749","volume":"206","author":"M Donners","year":"2005","unstructured":"Donners M, Verluyten MJ, Bouwman FG, Mariman E, Devrese B et al (2005) Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol 206:39\u201345","journal-title":"J Pathol"},{"key":"1_CR000145","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.2353\/ajpath.2006.050471","volume":"168","author":"M Slevin","year":"2006","unstructured":"Slevin M, Elasbali AB, Turu M, Krupinski J, Badimon L et al (2006) Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol 168:1004\u20131021","journal-title":"Am J Pathol"},{"key":"1_CR000146","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1074\/mcp.M800254-MCP200","volume":"8","author":"H Roelofsen","year":"2009","unstructured":"Roelofsen H, Dijkstra M, Weening D, de Vries MP, Hoek A, Vonk RJ (2009) Comparison of isotope-labeled amino acid incorporation rates (CILAIR) provides a quantitative method to study tissue secretomes. Mol Cell Proteomics 8:316\u2013324","journal-title":"Mol Cell Proteomics"},{"key":"1_CR000147","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/pmic.200300389","volume":"3","author":"MC Dur\u00e1n","year":"2003","unstructured":"Dur\u00e1n MC, Mas S, Martin-Ventura JL, Meilhac O, Michel JB et al (2003) Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 3:973\u2013978","journal-title":"Proteomics"},{"issue":"1\u20132","key":"1_CR000148","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2007.01.077","volume":"562","author":"MC Dur\u00e1n","year":"2007","unstructured":"Dur\u00e1n MC, Martin-Ventura JL, Mohammed S, Barderas MG, Mas S et al (2007) Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol 562(1\u20132):119\u2013129","journal-title":"Eur J Pharmacol"},{"key":"1_CR000149","first-page":"141","volume":"357","author":"MC Duran","year":"2006","unstructured":"Duran MC, Mart\u00edn-Ventura JL, Mas S, Barderas MG, Darde V et al (2006) Characterization of the human atherome plaque secretome by proteomic analysis. Methods Mol Biol 357:141\u2013150","journal-title":"Methods Mol Biol"},{"key":"1_CR000150","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/pr0500197","volume":"4","author":"F Vivanco","year":"2005","unstructured":"Vivanco F, Martin-Ventura JL, Duran MC, Barderas MG, Blanco-Colio L et al (2005) Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 4:1181\u20131191","journal-title":"J Proteome Res"},{"key":"1_CR000151","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1161\/01.CIR.0000136814.87170.B1","volume":"110","author":"JL Mart\u00edn-Ventura","year":"2004","unstructured":"Mart\u00edn-Ventura JL, Duran MC, Blanco-Colio L, Meilhac O, Leclercq A et al (2004) Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 110:2216\u20132219","journal-title":"Circulation"},{"key":"1_CR000152","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/01.ATV.0000220108.97208.67","volume":"26","author":"JL Martin-Ventura","year":"2006","unstructured":"Martin-Ventura JL, Nicolas V, Houard X, Blanco-Colio L, Leclercq A et al (2006) Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol 26:1337\u20131343","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1_CR000153","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.jprot.2011.12.005","volume":"75","author":"F de la Cuesta","year":"2011","unstructured":"de la Cuesta F, Barderas MG, Calvo E, Zubiri I, Maroto AS, Darde VM, Martin-Rojas T, Gil-Dones F, Posada-Ayala M, Tejerina T, Lopez JA, Vivanco F, Alvarez-Llamas G (2011) Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics 75(10): 2960\u20132971","journal-title":"J Proteomics"},{"key":"1_CR000154","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/81137","volume":"18","author":"O Fiehn","year":"2000","unstructured":"Fiehn O, Kopka J, Dormann P, Altmann T, Trethwey R, Wilmitzer J (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18:1157\u20131161","journal-title":"Nat Biotechnol"},{"key":"1_CR000155","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK, Lindon J, Holmes E (1999) Metabolomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NRM spectroscopic data. Xenobiotica 29:1181\u20131189","journal-title":"Xenobiotica"},{"key":"1_CR000156","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1039\/b418288j","volume":"130","author":"W Dunn","year":"2005","unstructured":"Dunn W, Bailey N, Johnso H (2005) Measuring the metabolome: current analytical technologies. Analyst 130:606\u2013625","journal-title":"Analyst"},{"key":"1_CR000157","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.toxlet.2003.09.011","volume":"146","author":"G Harrigan","year":"2004","unstructured":"Harrigan G, LaPlante R, Cosma G, Cockerell G, Goodacre R, Maddox J et al (2004) Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. Toxicol Lett 146:197\u2013205","journal-title":"Toxicol Lett"},{"key":"1_CR000158","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0731-7085(03)00410-2","volume":"33","author":"EM Lenz","year":"2003","unstructured":"Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF (2003) A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33:1103\u20131115","journal-title":"J Pharm Biomed Anal"},{"key":"1_CR000159","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s11745-005-1460-7","volume":"40","author":"ES Musiek","year":"2005","unstructured":"Musiek ES, Yin H, Milne GL, Morrow JD (2005) Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40:987\u2013994","journal-title":"Lipids"},{"key":"1_CR000160","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.aca.2008.10.059","volume":"632","author":"HJ Cho","year":"2009","unstructured":"Cho HJ, Kim JD, Lee WY, Chung BC, Choi MH (2009) Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Anal Chim Acta 632:101\u2013108","journal-title":"Anal Chim Acta"},{"key":"1_CR000161","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29:1383\u20131391","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1_CR000162","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1021\/pr900668v","volume":"8","author":"J Teul","year":"2009","unstructured":"Teul J, Ruperez FJ, Garcia A, Vaysse J, Balayssac S, Gilard V et al (2009) Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. J Proteome Res 8: 5580\u20135589","journal-title":"J Proteome Res"},{"key":"1_CR000163","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jacc.2007.09.055","volume":"51","author":"M Mayr","year":"2008","unstructured":"Mayr M, Yusuf S, Weir G, Chung YL, Mayr U, Yin X et al (2008) Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51:585\u2013594","journal-title":"J Am Coll Cardiol"},{"key":"1_CR000164","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/jssc.201000395","volume":"33","author":"X Chen","year":"2010","unstructured":"Chen X, Liu L, Palacios G, Gao J, Zhang N, Li G, Lu J, Song T, Zhang Y (2010) Plasma metabolomics reveals biomarkers of the atherosclerosis. J Sep Sci 33:2776\u20132783","journal-title":"J Sep Sci"},{"key":"1_CR000165","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.talanta.2009.05.010","volume":"79","author":"F Zhang","year":"2009","unstructured":"Zhang F, Jia Z, Gao P, Kong H, Li X, Chen J et al (2009) Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry. Talanta 79:836\u2013844","journal-title":"Talanta"},{"key":"1_CR000166","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.108.816116","volume":"119","author":"AT Turer","year":"2009","unstructured":"Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der WJ, Mathew JP et al (2009) Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia\/reperfusion. Circulation 119:1736\u20131746","journal-title":"Circulation"},{"key":"1_CR000167","doi-asserted-by":"publisher","first-page":"H936","DOI":"10.1152\/ajpheart.00870.2007","volume":"294","author":"G Zhao","year":"2008","unstructured":"Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S et al (2008) Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 294:H936\u2013H943","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1_CR000168","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1172\/JCI35111","volume":"118","author":"GD Lewis","year":"2008","unstructured":"Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M et al (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118:3503\u20133512","journal-title":"J Clin Invest"},{"key":"1_CR000169","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00216-009-2610-6","volume":"394","author":"M Vallejo","year":"2009","unstructured":"Vallejo M, Garcia A, Tunon J, Garcia-Martinez D, Angulo S, Martin-Ventura JL et al (2009) Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem 394:1517\u20131524","journal-title":"Anal Bioanal Chem"},{"key":"1_CR000170","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/pr800615t","volume":"8","author":"C von Zur Muhlen","year":"2009","unstructured":"von Zur Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N et al (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 8:335\u2013345","journal-title":"J Proteome Res"},{"key":"1_CR000171","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jms.505","volume":"38","author":"SA Schwartz","year":"2003","unstructured":"Schwartz SA, Reyzer ML, Capriol RM (2003) Direct tissue analysis using matrix-assisted laser desorption\/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom 38:699\u2013708","journal-title":"J Mass Spectrom"},{"key":"1_CR000172","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2011.03.044","volume":"217","author":"N Zaima","year":"2011","unstructured":"Zaima N, Sasaki T, Tanaka H, Cheng XW, Onoue K, Hayasaka T, Goto-Inoue N, Enomoto H, Unno N, Kuzuya M, Setou M (2011) Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions. Atherosclerosis 217:427\u2013432","journal-title":"Atherosclerosis"},{"key":"1_CR000173","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ar.21103","volume":"293","author":"AC Grey","year":"2010","unstructured":"Grey AC, Gelasco AK, Section J, Moreno-Rodriguez RA, Krug EL, Schey KL (2010) Molecular morphology of the chick heart visualized by MALDI imaging mass spectrometry. Anat Rec (Hoboken) 293:821\u2013828","journal-title":"Anat Rec (Hoboken)"},{"key":"1_CR000174","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1021\/ac202779h","volume":"84","author":"RF Menger","year":"2012","unstructured":"Menger RF, Stutts WL, Anbukumar DS, Bowden JA, Ford DA, Yost RA (2012) MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model. Anal Chem 84:1117\u20131125","journal-title":"Anal Chem"},{"key":"1_CR000175","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1021\/cr100012c","volume":"110","author":"K Chughtai","year":"2010","unstructured":"Chughtai K, Heeren RM (2010) Mass spectrometric imaging for biomedical tissue \u00adanalysis. Chem Rev 110:3237\u20133277","journal-title":"Chem Rev"},{"key":"1_CR000176","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tibtech.2010.12.002","volume":"29","author":"EH Seeley","year":"2011","unstructured":"Seeley EH, Caprioli RM (2011) MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 29:136\u2013143","journal-title":"Trends Biotechnol"},{"key":"1_CR000177","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1039\/b902356a","volume":"5","author":"CE Wheelock","year":"2009","unstructured":"Wheelock CE, Wheelock AM, Kawashima S, Diez D, Kanehisa M, van Erk M, Kleemann R, Haeggstr\u00f6m JZ, Goto S (2009) Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol BioSyst 5:588\u2013602","journal-title":"Mol BioSyst"},{"key":"1_CR000178","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/emmm.201000063","volume":"2","author":"SA Ramsey","year":"2010","unstructured":"Ramsey SA, Gold ES, Aderem A (2010) A \u00adsystems biology approach to understanding atherosclerosis. EMBO Mol Med 2:79\u201389","journal-title":"EMBO Mol Med"},{"key":"1_CR000179","doi-asserted-by":"crossref","unstructured":"Jain KK (2010) Technologies for discovery of biomarkers. In: The handbook of biomarkers. Springer, New York. Jain Pharma-Biotech, Basel, Switzerland","DOI":"10.1007\/978-1-60761-685-6_2"},{"key":"1_CR000180","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.108.847699","volume":"121","author":"AJ Lusis","year":"2010","unstructured":"Lusis AJ, Weiss JN (2010) Cardiovascular networks: systems-based approaches to cardiovascular disease. Circulation 121:157\u2013170","journal-title":"Circulation"},{"key":"1_CR000181","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.jprot.2011.12.005","volume":"75","author":"F de la Cuesta","year":"2012","unstructured":"de la Cuesta F, Barderas MG, Calvo E, Zubiri I, Maroto AS, Darde VM, Martin-Rojas T, Gil-Dones F, Posada-Ayala M, Tejerina T, Lopez JA, Vivanco F, Alvarez-Llamas G (2012) Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J Proteomics 75:2960\u20132971","journal-title":"J Proteomics"},{"key":"1_CR000182","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gkq973","volume":"39","author":"D Szklarczyk","year":"2011","unstructured":"Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jense LJ, von Mering C (2011) The STRING database in 2011: functional interaction networks of proteins globally integrated and scored. Nucleic Acids Res 39:D561\u20138","journal-title":"Nucleic Acids Res"}],"container-title":["Methods in Molecular Biology","Vascular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-405-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T15:37:04Z","timestamp":1706197024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-405-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781627034043","9781627034050"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-405-0_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"20 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}